
Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO) – Equities research analysts at Scotiabank raised their FY2027 earnings per share (EPS) estimates for shares of Cameco in a research note issued on Tuesday, October 13th. Scotiabank analyst O. Wowkodaw now expects that the basic materials company will post earnings of $1.44 per share for the year, up from their prior estimate of $1.30. The consensus estimate for Cameco’s current full-year earnings is $1.07 per share.
Cameco (NYSE:CCJ – Get Free Report) (TSE:CCO) last issued its earnings results on Friday, July 31st. The basic materials company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.13). The company had revenue of $573.06 million during the quarter, compared to the consensus estimate of $579.60 million. Cameco had a return on equity of 7.59% and a net margin of 10.20%. The firm’s revenue for the quarter was down 6.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.71 EPS.
Cameco Trading Up 0.1%
Shares of CCJ opened at $86.20 on Wednesday. Cameco has a twelve month low of $77.70 and a twelve month high of $135.24. The stock has a market cap of $37.54 billion, a PE ratio of 146.11, a P/E/G ratio of 1.76 and a beta of 1.17. The company has a quick ratio of 2.10, a current ratio of 3.06 and a debt-to-equity ratio of 0.14. The business’s 50-day moving average price is $94.89 and its 200-day moving average price is $101.94.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of CCJ. Bank of America Corp DE purchased a new stake in Cameco during the second quarter valued at about $735,498,000. Canada Pension Plan Investment Board bought a new stake in shares of Cameco in the 2nd quarter valued at about $420,346,000. BlackRock Inc. bought a new stake in shares of Cameco in the 2nd quarter valued at about $381,091,000. Cibc World Market Inc. bought a new stake in shares of Cameco in the 2nd quarter valued at about $354,022,000. Finally, Amundi boosted its holdings in Cameco by 13.7% during the 2nd quarter. Amundi now owns 2,992,074 shares of the basic materials company’s stock valued at $304,773,000 after acquiring an additional 359,375 shares during the period. Hedge funds and other institutional investors own 70.21% of the company’s stock.
About Cameco
Cameco Corporation is a Canadian uranium company headquartered in Saskatoon, Saskatchewan. It is one of the world’s major suppliers of uranium, producing uranium concentrates used to generate nuclear power. The company’s operations span uranium exploration, mining, milling, refining, conversion and fuel manufacturing.
Cameco operates or has interests in uranium assets in Canada, the United States and Kazakhstan. Its Canadian portfolio includes the McArthur River and Cigar Lake mines and the Key Lake and McClean Lake milling operations in northern Saskatchewan.
Featured Stories
- Five stocks we like better than Cameco
- A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.
